Literature DB >> 7894990

Acute infective exacerbations of chronic bronchitis.

P Ball1, J M Harris, D Lowson, G Tillotson, R Wilson.   

Abstract

Patients with an acute infective exacerbation of chronic bronchitis (AECB) (n = 471) were enrolled into a computer-based general-practice study to determine whether features of past history, presenting symptoms, or findings on examination were predictive of failure to recover. The median age was 68, 56.3% were male, and 82% were current or ex-smokers. All had daily sputum production and 57.5% had moderate or severe airflow obstruction. During the AECB 11.5% were pyrexial, and 80.7% had abnormal auscultatory findings; about half had moderate to severe increases in dyspnoea and airflow obstruction, and the majority had increases in sputum volume and/or purulence. The median number of AECBs in the previous year was three, and one-third of patients had cardiopulmonary disease. The only factors significantly (p < 0.05) predicting failure to recover from an AECB were historical. Neither clinical features at presentation nor antibiotic treatment affected recovery. Coexistent cardiopulmonary disease was a risk factor for returning with a chest problem and for being referred to hospital. The number of chest infections in the previous 12 months was a risk factor for returning with a chest problem. The higher the number of chest infections, the higher the odds of returning with a chest problem. The best combination predicting return with a chest problem was history of cardiopulmonary disease and more than four previous AECBs in the last 12 months. The sensitivity was 75% and specificity 47%.

Entities:  

Mesh:

Year:  1995        PMID: 7894990

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  29 in total

1.  Diesel exhaust particles override natural injury-limiting pathways in the lung.

Authors:  N Chaudhuri; C Paiva; K Donaldson; R Duffin; L C Parker; I Sabroe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-30       Impact factor: 5.464

2.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.

Authors:  A Bhowmik; T A Seemungal; R J Sapsford; J A Wedzicha
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Intermediate care--Hospital-at-Home in chronic obstructive pulmonary disease: British Thoracic Society guideline.

Authors: 
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

4.  Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa.

Authors:  A Rutman; R Dowling; P Wills; C Feldman; P J Cole; R Wilson
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

5.  Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis.

Authors:  I S Woolhouse; S L Hill; R A Stockley
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

6.  Reducing reconsultations for acute lower respiratory tract illness with an information leaflet: a randomized controlled study of patients in primary care.

Authors:  J T Macfarlane; W F Holmes; R M Macfarlane
Journal:  Br J Gen Pract       Date:  1997-11       Impact factor: 5.386

Review 7.  Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature.

Authors:  Helen Doll; Marc Miravitlles
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 8.  Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management.

Authors:  Don Hayes; Keith C Meyer
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

9.  Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections.

Authors:  M Cazzola; M G Matera; C F Donner
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

10.  Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care.

Authors:  Carl Llor; Silvia Hernández; Anna Ribas; Carmen Alvarez; Josep Maria Cots; Carolina Bayona; Isabel González; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.